Prescription ID | TCMF1645 |
Pinyin Name | Shen Fu Tang |
Chinese Name | 参附汤 |
English Name | Ginseng Aconitum Decoction |
Function Description | |
Indications | None |
Disease ICD-11 Category | |
Human Tissues Associated with Indication | |
Reference | Chinese Classical Prescriptions |
Reference Book/link | ISBN 7-5023-3930-2 |
Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
---|---|---|---|---|
TCMH1721 | Panax ginseng | 人参 | TCMH1721 | GBVE1679-11 |
TCMH623 | Aconitum carmichaeli | 附子 | TCMH623 | ITSAH2410-14 |
TCMH1903 | Zingiber officinale | 生姜 | TCMH1903 | ITSAO3969-14 |
TCMH388 | Ziziphus jujuba | 大枣 | TCMH388 | ITSAM869-14 |
Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
---|---|---|---|---|
TCMT101 | PTPN1 | Protein-tyrosine phosphatase 1B | Hydrolase | P18031 |
TCMT102 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | Hydrolase | P24666 |
TCMT103 | PTPRF | Receptor-type tyrosine-protein phosphatase F (LAR) | Hydrolase | P10586 |
TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
TCMT130 | ALOX5 | Arachidonate 5-lipoxygenase | Oxidoreductase | P09917 |
TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
TCMT133 | CA1 | Carbonic anhydrase I | Lyase | P00915 |
TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
Target ID | Target Name |
---|---|
TCMT1170 | Enterobacter cloacae |
TCMT1172 | Staphylococcus aureus subsp. aureus RN4220 |
TCMT1175 | Human immunodeficiency virus |
TCMT1176 | Streptococcus pneumoniae |
TCMT1178 | Actinomyces viscosus |
TCMT1180 | Human herpesvirus 2 |
TCMT1181 | Mycobacterium tuberculosis H37Ra |
TCMT1182 | Streptococcus sanguinis |
TCMT1188 | Leishmania braziliensis |
TCMT1189 | Pseudomonas fluorescens |
GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
---|---|---|---|
[BP] GO:0000302 | response to reactive oxygen species | AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC | 2.62367 |
[BP] GO:0001101 | response to acid chemical | AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGES, PTGS2, SRC | 3.63014 |
[BP] GO:0001503 | ossification | ALPL, EGFR, MMP2, MMP9, TEK | 2.48635 |
[BP] GO:0001505 | regulation of neurotransmitter levels | ACHE, CYP1B1, DRD1, DRD2, DRD3, EGFR, INSR, MAOA, PTGS2, SMAD3, TRPV1 | 6.24325 |
[BP] GO:0001516 | None | PTGES, PTGS1, PTGS2 | 3.03377 |
[BP] GO:0001525 | angiogenesis | CYP1B1, KDR, MMP2, PIK3CA, PIK3CB, PTGS2, TEK | 2.6327 |
[BP] GO:0001659 | None | ADORA1, DRD1, DRD2, TRPV1 | 3.38999 |
[BP] GO:0001666 | response to hypoxia | ADORA1, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK | 4.30804 |
[BP] GO:0001676 | long-chain fatty acid metabolic process | CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGES, PTGS1, PTGS2, TBXAS1 | 6.09927 |
[BP] GO:0001775 | cell activation | ALOX5, AXL, EGFR, FLT3, FUT7, HSPA1A, MMP9, PIK3CA, PIK3CB, RORC, SMAD3, SRC, TRPV1 | 2.65512 |
KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
---|---|---|
Acute myeloid leukemia_Homo sapiens_hsa05221 | PIK3CA, FLT3, PIM1, PIK3CB | 3.679 |
Adherens junction_Homo sapiens_hsa04520 | PTPN1, SMAD3, CSNK2A1, SRC, INSR, MET, EGFR, IGF1R | 8.1153 |
Adipocytokine signaling pathway_Homo sapiens_hsa04920 | PPARA | 0.596 |
Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | PIK3CA, PIK3CB | 0.9083 |
AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | SMAD3, PIK3CA, MMP2, PIM1, PIK3CB, F3 | 4.857 |
Alcoholism_Homo sapiens_hsa05034 | MAOA, DRD1, DRD2 | 1.3799 |
Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | PIK3CA, INSR, PIK3CB | 2.9662 |
Amoebiasis_Homo sapiens_hsa05146 | PIK3CA, PIK3CB | 1.1455 |
Amphetamine addiction_Homo sapiens_hsa05031 | MAOA, DRD1 | 1.3999 |
AMPK signaling pathway_Homo sapiens_hsa04152 | PIK3CA, INSR, PIK3CB, IGF1R | 2.6108 |